Decreased neonatal jaundice readmission rate after implementing hyperbilirubinemia guidelines and universal screening for bilirubin.
Readmission rate for neonatal jaundice approximate 10 per 1000 live births. After applying hyperbilirubinemia guidelines and universal screening for bilirubin in term and near-term newborns, the readmission rate declined significantly from 24 to 3.7 per 1000 live births. Decreased readmission rate for neonatal jaundice may reduce kernicterus rate and health care costs. Further studies are necessary to explore these potential benefits.
Alkalay
Arie L
AL
Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. arie.alkalay@cshs.org
Bresee
Catherine J
CJ
Simmons
Charles F
CF
D001663:Bilirubin / Q000097:blood*; D006801:Humans; D051556:Hyperbilirubinemia, Neonatal / Q000175:diagnosis*; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D007567:Jaundice, Neonatal / Q000453:epidemiology / Q000517:prevention & control*; D007647:Kernicterus / Q000517:prevention & control; D007902:Length of Stay; D015997:Neonatal Screening; D009725:Nurseries, Hospital; D010359:Patient Readmission / Q000706:statistics & numerical data*; D017410:Practice Guidelines as Topic
D001663:Bilirubin